Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages

Key Points

• Hyperfine has a consensus “Hold” rating from five brokerages: three buys, one hold and one sell. The average 12-month price target is $2.03, with recent targets ranging from $1.60 to $2.00.
• HYPR opened at $0.90, near its one-year low of $0.85 and below its 50-day and 200-day moving averages. The company has a market capitalization of about $95 million and remains deeply unprofitable.
• In its latest quarter, Hyperfine reported an adjusted loss of $0.09 per share, in line with estimates, while revenue of $3.9 million fell short of the $4.13 million forecast. Analysts expect a full-year loss of approximately $0.34 per share.

Shares of Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) have been given a consensus rating of "Hold" by the five ratings firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $2.0333.

Several brokerages have recently commented on HYPR. Weiss Ratings reissued a "sell (d-)" rating on shares of Hyperfine in a report on Friday, July 17th. BTIG Research assumed coverage on shares of Hyperfine in a research note on Wednesday, April 29th. They issued a "buy" rating and a $2.00 target price on the stock. Finally, B. Riley Financial reiterated a "buy" rating and set a $1.60 target price (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th.

Hyperfine Stock Performance

NASDAQ HYPR opened at $0.90 on Tuesday. The company's 50 day simple moving average is $1.16 and its two-hundred day simple moving average is $1.24. The company has a debt-to-equity ratio of 0.36, a current ratio of 6.15 and a quick ratio of 5.45. Hyperfine has a 1 year low of $0.85 and a 1 year high of $2.22. The stock has a market capitalization of $95.00 million, a PE ratio of -2.36 and a beta of 1.43.

Hyperfine (NASDAQ:HYPR - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) EPS for the quarter, meeting analysts' consensus estimates of ($0.09). The firm had revenue of $3.90 million during the quarter, compared to analyst estimates of $4.13 million. Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. Analysts predict that Hyperfine will post -0.34 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Hyperfine

A number of hedge funds and other institutional investors have recently modified their holdings of HYPR. EP Wealth Advisors LLC bought a new stake in Hyperfine in the 4th quarter worth $34,000. Sanctuary Advisors LLC raised its stake in shares of Hyperfine by 130.9% during the fourth quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company's stock valued at $39,000 after acquiring an additional 22,638 shares during the last quarter. Millennium Management LLC bought a new position in shares of Hyperfine during the fourth quarter valued at about $55,000. Cerity Partners LLC purchased a new stake in shares of Hyperfine during the fourth quarter worth about $59,000. Finally, Tortoise Investment Management LLC boosted its holdings in shares of Hyperfine by 60.0% during the fourth quarter. Tortoise Investment Management LLC now owns 72,000 shares of the company's stock worth $71,000 after purchasing an additional 27,000 shares during the period. Institutional investors own 15.03% of the company's stock.

Hyperfine Company Profile

Hyperfine, Inc NASDAQ: HYPR is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company's flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient's bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source